Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis.
- 1 April 1995
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 91 (4) , 276-279
- https://doi.org/10.1111/j.1600-0404.1995.tb07004.x
Abstract
The cytotoxic cytokines tumor necrosis factor alpha (TNF-alpha) and lymphotoxin (LT) possess toxic activity against myelin and/or oligodendrocytes in vitro. Multiple sclerosis (MS) plaques within the central nervous system (CNS) are infiltrated by peripheral blood mononuclear cells (PBMC). In this study the production of TNF-alpha and LT by PBMC in active MS were measured. PBMC were isolated from the blood of MS patients in relapse and also patients with other neurological diseases (OND) and healthy controls (HC). Isolated cells were cultured unstimulated or stimulated with phytohemagglutinin A (PHA), lipopolysaccharide (LPS) and myelin basic protein (MBP) – a hypothetical autoantigen for MS. Cytokine production was assessed using ELISA method. In the MS group, PBMC without stimulation as well as after stimulation with MBP displayed a significantly increased production of TNF-alpha. LT production was similar in MS and control groups. These results suggest that TNF-alpha but not LT is overproduced by PBMC during MS relapse.Keywords
This publication has 28 references indexed in Scilit:
- Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patientsActa Neurologica Scandinavica, 1993
- T Cell Lymphokine-Induced Secretion of Cytokines by Monocytes from Patients with Multiple SclerosisCellular Immunology, 1993
- Markers of Activated T Lymphocytes and T Cell Receptor Gamma/ Delta+ in Patients with Multiple SclerosisEuropean Neurology, 1993
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- In vitro study of mediators of inflammation in multiple sclerosisJournal of Clinical Immunology, 1989
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988
- LymphotoxinAnnual Review of Immunology, 1988
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988
- Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesionsAnnals of Neurology, 1986
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983